Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab

Joint Bone Spine. 2017 Mar;84(2):235-236. doi: 10.1016/j.jbspin.2016.01.008. Epub 2016 May 26.
No abstract available

Keywords: BAFF; Belimumab; Lupus nephritis; Rituximab; SLE.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy*
  • Rituximab / therapeutic use*
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Immunosuppressive Agents
  • Rituximab
  • belimumab